| Schedule of Movement of Warrant |
For the six months ended March 31, 2026, the movement of warrants is as follows: | | | For the six months ended March 31, 2026 | | | | | Total Valuation | | | Issuance | | | | | US$ | | | Share | | | Valuation | | | Average exercise price | | | Balance at beginning of the period | | $ | 494,048 | | | | 5,708 | | | $ | 494,048 | | | $ | 87 | | | Issuance | | | — | | | | — | | | | — | | | | — | | | Change in fair value of warrant liability | | | (128,286 | ) | | | 5,708 | | | | (128,286 | ) | | | 22 | | | Exercise | | | — | | | | — | | | | — | | | | — | | | Balance at end of the period | | $ | 365,762 | | | | 5,708 | | | $ | 365,762 | | | $ | 64 | | For the six months ended March 31, 2025, the movement of warrants is as follows: | | | For the six months ended March 31, 2025 | | | | | Total Valuation | | | Issuance | | | | | US$ | | | Share | | | Valuation | | | Average exercise price | | | Balance at beginning of the period | | $ | — | | | | — | | | $ | — | | | $ | — | | | Issuance(a) | | | 14,493,455 | | | | 396,040 | | | | 14,493,455 | | | | 37 | | | Change in fair value of warrant liability | | | (3,734,131 | ) | | | — | | | | (3,734,131 | ) | | | — | | | Exercise | | | 9,909,270 | | | | 364,750 | | | | 9,909,270 | | | | 27 | | | Balance at end of the period | | $ | 850,054 | | | | 31,290 | | | $ | 850,054 | | | $ | 27 | |
|
| Schedule of Binominal Tree Pricing Model |
The fair value of warrants aforementioned was determined using the Binominal Tree pricing model and the following assumptions: | | | March 31, | | | September 30, | | | September 22, | | | April 29, | | | February 17, | | | October 31, | | | | | 2026 | | | 2025 | | | 2025 | | | 2025 | | | 2025 | | | 2024 | | | Share price | | $ | 75 | | | $ | 97.5 | | | $ | 104.63 | | | $ | 123 | | | $ | 227 | | | $ | 321.75 | | | Share price (Pre-splits) | | | 1.5 | | | | 1.95 | | | | 2.09 | | | | 2.46 | | | | 4.49 | | | | 0.43 | | | Exercise price | | | 75.75 | | | | 75.75 | | | | 75.75 | | | | 75.75 | | | | 75.75 | | | | 75.75 | | | Exercise price (Pre-splits) | | | 1.515 | | | | 1.515 | | | | 1.515 | | | | 1.515 | | | | 1.515 | | | | 0.101 | | | Expected dividend yield | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | | | Risk free interest rate | | | 3.85 | % | | | 3.68 | % | | | 3.65 | % | | | 3.74 | % | | | 4.32 | % | | | 4.15 | % | | Expected life | | | 3.6 | | | | 4.1 | | | | 4.1 | | | | 4.5 | | | | 4.7 | | | | 5 | | | Expected volatility | | | 88.6 | % | | | 100.3 | % | | | 94.7 | % | | | 102.9 | % | | | 103.2 | % | | | 100.5 | % |
|
| Schedule of stock-based compensation expenses |
The stock-based compensation expenses incurred by the Company for the six months ended March 31, 2026 and 2025 are as follows: | | | For the Six Months Ended March 31, | | | | | 2026 | | | 2025 | | | | | (Unaudited) | | | (Unaudited) | | | Research and development expenses | | $ | 8,667,172 | | | | 1,419,000 | | | General and administrative expenses | | | 4,090,761 | | | | — | | | Selling and marketing expenses | | | 708,687 | | | | — | | | Total stock-based compensation | | $ | 13,466,620 | | | $ | 1,419,000 | |
|